Clinical Trial Details
EORTC-90061
Back to Clinical Trials Database
Multicenter parallel phase II trial of BI 2536 administrered as one hour i.v. infusion every 3 weeks in defined cohorts of patients with various solid tumors. A new drug screening program of the EORTC Network of Core Institutions (NOCI)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 25-Jul-2007 Date Step1 close: 18-Sep-2008 Date Step2 close: 18-Sep-2008 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | All Groups: 185 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00526149 |
| NCT number | NCT00526149 |
| EudraCT | 2006-004529-27 |
